Nanosphere to Announce Third Quarter Financial Results & Host Investor Call on Monday, November 9
November 02, 2015 08:00 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., Nov. 2, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing medicine through targeted and flexible molecular diagnostics, announced today that it will report...
Impact of Verigene Blood Culture Tests Highlighted by Five Studies Presented at ICAAC 2015
September 22, 2015 08:00 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., Sept. 22, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing medicine through targeted and flexible molecular diagnostics, announced that new clinical data...
Nanosphere Receives FDA Clearance for First-of-Its-Kind Flexible Respiratory Pathogens Test
September 08, 2015 08:00 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., Sept. 8, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing the practice of medicine through targeted molecular diagnostics, today announced it has received...
Nanosphere Announces Record Q2 2015 Results
August 10, 2015 16:01 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., Aug. 10, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing medicine through targeted molecular diagnostics, today reported financial and operating results...
Nanosphere Announces Amendment to $30 Million Term Loan Facility, Release of Q2 2015 Results and Conference Call and Schedules 2015 Annual Meeting of Stockholders
July 31, 2015 08:00 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., July 31, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing medicine through targeted molecular diagnostics, announced today that it has amended certain...
New Studies Highlight Antibiotic Resistance Detection With Nanosphere's Verigene Blood Culture Tests
June 22, 2015 16:01 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., June 22, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that seven studies evaluating...
Nanosphere Announces $4.4 Million at the Market Registered Direct Offering
June 08, 2015 16:14 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., June 8, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced today that it has entered into a...
Eighteen New Verigene Clinical and Economic Studies Presented at CVS, ECCMID and MAD-ID 2015
May 27, 2015 16:01 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., May 27, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that 18 studies performed by...
Nanosphere Announces Closing of New and Expanded Debt Facility and $4.4 Million at the Market Registered Direct Offering
May 15, 2015 09:00 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., May 15, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, announced today the closing of its previously...
Nanosphere Announces Record Q1 2015 Results, New and Expanded Debt Facility, $4.4 Million at the Market Registered Direct Offering and Next Generation Verigene System Progress
May 11, 2015 17:30 ET
|
Nanosphere, Inc.
Corporate Highlights:
Record Q1 revenues of $4.6 million confirming full year guidance
New and Expanded Debt Facility
Pricing of $4.4 million at the market registered...